Health Condition 1: E888- Other specified metabolic disorders
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: I) Patients willing to participate in clinical trial II) Patients having impaired fasting glucose (Fasting blood glucose 126â??200 mg/dl) along with any 2 or more below mentioned conditions; Abdominal obesity (waist circumference >40 inches in men and >35 inches in women), Hyper - triglyceridaemia (S. triglycerides level 150â??500 mg/dl), Low highdensity lipoprotein (HDL) cholesterol (S.HDL cholesterol
Exclusion criteria
Exclusion criteria: 1) Patients having abdominal obesity (waist circumference 2) Patients having Hyper-triglyceridemia (S. triglycerides level >500 mg/dl) 3) Patients having High density lipoprotein (HDL) cholesterol (S. HDL cholesterol >40 mg/dl for men and >50 mg/dl for women) 4) Patients having Blood pressure (Systolic blood pressure 159 mmHg and/or diastolic blood pressure 99 mmHg) 5) Patients having Impaired fasting glucose (Fasting plasma glucose 200 mg/dl) 6) Pregnant and lactating women 7) Patients with type 1 diabetes mellitus 8) Patients already taking Anti-diabetic, Anti-hypertensive, anti-hyperlipidemic drugs or weight lowering drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the Fasting Blood Sugar levelTimepoint: From baseline to 56 days of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the Triglycerides, HDL, waist circumference, Framinghams 10-year cardiac risk score and Change in sign and symptoms of Sthaulya and Prameha.Timepoint: Baseline and 56 days after treatment | — |
Countries
India
Contacts
National Institute of Ayurveda, Deemed to be University, Jaipur